Compounds > thiazolidines
Page last updated: 2024-08-21

thiazolidines and Atherogenesis

thiazolidines has been researched along with Atherogenesis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, D; Higashikuni, Y; Hirata, Y; Salim, HM; Sata, M; Shimabukuro, M; Soeki, T; Tanaka, K; Yagi, S1
Abdalla, DS; Boscá, L; César, FA; de Las Heras, B; Lima, MC; Pitta, IR; Rudnicki, M1
Rapezzi, C; Volpe, M1
Demuth, HU; Li, L; Zukowska, Z1
Gleissner, CA; Ley, K; Nadler, J; Sanders, JM1

Reviews

1 review(s) available for thiazolidines and Atherogenesis

ArticleYear
Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
    Advances in experimental medicine and biology, 2006, Volume: 575

    Topics: Atherosclerosis; Blood Vessels; Dipeptidyl Peptidase 4; Humans; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Neuropeptide Y; Pentanoic Acids; Serine Proteinase Inhibitors; Thiazoles; Thiazolidines; Vasoconstriction

2006

Other Studies

4 other study(ies) available for thiazolidines and Atherogenesis

ArticleYear
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
    Vascular pharmacology, 2017, Volume: 96-98

    Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Exenatide; Female; Genetic Predisposition to Disease; Incretins; Inflammation Mediators; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Peptides; Phenotype; Plaque, Atherosclerotic; Pyrazoles; RAW 264.7 Cells; Signal Transduction; Thiazolidines; Time Factors; Vasodilation; Venoms

2017
New indole-thiazolidine attenuates atherosclerosis in LDLr(-/-) mice.
    Vascular pharmacology, 2015, Volume: 71

    Topics: Animals; Atherosclerosis; Cell Line; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Peroxisome Proliferator-Activated Receptors; Receptors, LDL; Thiazolidinediones; Thiazolidines

2015
[Residual risk in cardiovascular prevention].
    Giornale italiano di cardiologia (2006), 2008, Volume: 9, Issue:4 Suppl 1

    Topics: Atherosclerosis; Blood Pressure; Body Weight; Cannabinoid Receptor Antagonists; Cannabinoids; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Follow-Up Studies; Humans; Hypolipidemic Agents; Kaplan-Meier Estimate; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Risk Factors; Smoking Cessation; Thiazolidines; Time Factors

2008
Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:6

    Topics: Adult; Aldehyde Reductase; Aldehydes; Atherosclerosis; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Foam Cells; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rhodanine; Risk Factors; Thiazolidines; Up-Regulation

2008